In May 2026, the owner of a Massachusetts aesthetic business pleaded guilty in federal court to injecting clients with unapproved botulinum toxin from illegitimate sources. The case followed 10 suspected botulism cases traced to that practice. It was a stark reminder that the stakes in aesthetic medicine are real.
Among filler complications, vascular occlusion stands alone in its severity and urgency. It is rare — estimates suggest it occurs in roughly 1 in 6,000 to 1 in 100,000 filler procedures, depending on the injection area and technique — but it is the complication that can cause permanent tissue damage, skin necrosis, or, in the most severe cases, vision loss. Every patient who receives dermal filler should understand what it is, what the warning signs are, and what a prepared provider should do when it occurs.
What Vascular Occlusion Is
Dermal fillers are injected into the soft tissue of the face. In certain areas, blood vessels run through that tissue. A vascular occlusion occurs when filler material enters a blood vessel — either by direct injection into the vessel or by compression of the vessel from outside — blocking blood flow to tissue downstream.
The consequences depend on which vessel is affected and whether the blockage is identified and treated quickly.
Soft tissue necrosis occurs when blood flow is cut off long enough that the tissue begins to die. This appears first as blanching (the skin turns white as blood flow stops), then progresses to mottled or purplish discoloration and blistering as the tissue dies. If caught and treated quickly, necrosis can be reversed or limited. If treated late or not at all, permanent scarring can result.
Vision complications are the most severe possible outcome. The blood vessels that supply the eye connect to the facial blood supply. In rare cases, filler entering the ophthalmic artery or its branches can cause partial or total vision loss, which may be permanent. This risk is higher in specific areas: the glabella (between the brows), the nose, the nasolabial folds, and the temporal region. It is the reason experienced injectors are particularly cautious in these zones.
Why Some Areas Carry Higher Risk
The anatomy of the face determines risk. Certain zones have blood vessels that run near the surface, in areas where injectors need to place product, or that connect directly to the arterial supply of the eye.
High-risk zones include: the glabella (supratrochlear and supraorbital arteries), the nose (angular and dorsal nasal arteries), the nasolabial folds (facial artery), the temple (temporal artery), and the lips (labial arteries). This doesn't mean these areas shouldn't be treated — experienced injectors perform these treatments safely every day. It means these areas require greater technical precision, a more conservative approach, and injectors who understand the anatomy and have protocols in place for complications.
What Warning Signs Look Like During or After Treatment
Vascular occlusion presents with recognizable signs. A patient who reports any of the following during or immediately after filler injection should receive immediate evaluation:
Blanching or whitening of the skin at or near the injection site — this indicates blood flow has stopped.
Severe or disproportionate pain at or beyond the injection site — pain that seems out of proportion to the procedure.
Visual symptoms — blurring, double vision, loss of vision in any part of the visual field. This is an emergency requiring immediate treatment and likely transfer to an emergency ophthalmologist.
Skin mottling or bluish discoloration that develops over minutes to hours after treatment.
Any of these symptoms in the context of a recent filler treatment should prompt you to return to the treatment provider immediately or go to an emergency room. Do not wait.
What a Prepared Provider Has and Does
The treatment for hyaluronic acid filler occlusion is hyaluronidase — an enzyme that dissolves HA filler by breaking its molecular bonds. Time is critical: the sooner hyaluronidase is administered in the affected area, the more tissue can be preserved.
A prepared practice:
•Has hyaluronidase on site at every appointment where HA filler is administered
•Has a written emergency protocol for vascular occlusion
•Can administer hyaluronidase immediately without waiting for a prescription or supply delivery
•Has a relationship with an emergency ophthalmologist or knows where to refer a patient with visual symptoms
•Obtains informed consent that specifically names vascular occlusion as a risk, not just generic "complications"
These are not luxury features. They are the standard of care for responsible filler practices. When evaluating a provider, asking whether they have hyaluronidase on site and what their complication protocol is gives you meaningful information about the practice's preparation.
What This Means for Your Consultation
The presence of complication protocols doesn't mean you should expect complications. It means you're choosing a provider who takes the procedure seriously. The absence of hyaluronidase on site, a provider who dismisses complication questions, or a consent form that mentions only bruising and swelling without naming vascular occlusion — these are signals worth taking seriously.
For any filler treatment in high-risk areas — the nose, between the brows, the temples, the nasolabial folds — the experience and anatomical knowledge of the injector matters more than any other factor. Ask specifically about their experience with those areas, how many treatments they perform per week, and what they do if something goes wrong.
This article is educational and does not constitute medical advice. If you experience visual changes, severe pain, or skin blanching during or after filler treatment, seek immediate medical attention.
Looking for a safety provider?